Clinical Trial: A Phase II Study With Exploratory Outcomes of Fucose Supplementation in GLUT1 Deficiency Syndrome

U.S., Feb. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07432490) titled 'A Phase II Study With Exploratory Outcomes of Fucose Supplementation in GLUT1 Deficiency Syndrome' on Feb. 14.

Brief Summary: This is a single-center, randomized, double-blind, placebo-controlled, cross-over study to evaluate the efficacy and safety of L-fucose supplementation in subjects with GLUT1 deficiency syndrome (GLUT1DS).

Study Start Date: May, 2026

Study Type: INTERVENTIONAL

Condition: Glut1 Deficiency GLUT1DS1

Intervention: DRUG: L-fucose

L-fucose will be administered as 500 mg/kg to a maximum of 10 g three times per day by mouth.

OTHER: Placebo

Placebo will be composed of micro-cellulose powder with a small amoun...